SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (7577)10/29/1998 4:47:00 PM
From: Starlight  Respond to of 17367
 
George - I'm back just in time. I can download the files you posted, so I'll get back to you soon. Here are the choices -- which file do you want to know about?:

Continuing Education Program for Physicians and Nurses

Interactive MMWR Morbidity and Mortality Tables

Bulletins from Around the World

Case Definitions for Infectious Conditions Under Public Health Surveillance



Betty



To: aknahow who wrote (7577)10/29/1998 4:47:00 PM
From: BostonView  Read Replies (1) | Respond to of 17367
 
Is there any chance that today's move means pending success to P3 and not just post-cnbc buyout speculation/ overall biotech sector strength? Any chance at all?

BV



To: aknahow who wrote (7577)10/29/1998 5:14:00 PM
From: Starlight  Read Replies (2) | Respond to of 17367
 
George - Uh-oh. The tables don't break down the deaths by specific illness, except for pneumonia and influenza. E-coli is lumped in with everything else, so there's no way to know if there are fewer deaths in certain cities from E-coli. I'll keep looking, and see what else I can find.

Betty


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News